Home > > > > Report Detail

North America Opioids Drug Market Forecast 2019-2027

Publisher Name :
Date: 17-Dec-2018
No. of pages: 82

KEY FINDINGS

The North America opioids drug market is expected to grow at a CAGR of 2.29% throughout the forecast period of 2019-2027. This regional market has been valued $ XX million and is predicted to reach $XX million by 2027. Circumstances like the rising incidences of opioid abuse and addiction and stringent regulatory conditions for opioid drug sales in the healthcare sector are impeding the growth of the market in the region.

MARKET INSIGHTS

The countries of the U.S. and Canada are mainly considered for this particular market study. The United States contributes the largest shares for the market. The increasing cases of road accidents & surgeries are proliferating the market growth. The opioid drugs are prescribed for relieving the pain associated with injury caused due to severe accidents which occurs very frequently in the congested transport routes in developed nations like that of the United States, Canada, among others. Also, some of these cases can lead to unfortunate cases of extreme spinal cord injuries that can cause associated incurable pains. Here, mostly opioids meds are prescribed. Pharmaceutical companies are investing in the development of novel opioid drugs due to its growing demand in the novel therapeutics for pain management.

COMPETITIVE INSIGHTS

Sun Pharmaceutical Industries Limited (Sun Pharma), Indivior, Inc., Daiichi Sankyo, Inc., Acura Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Insys Therapeutics, Inc., Allergan PLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lannett Co. Inc., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Lupin Ltd. and Teva Pharmaceutical Industries Ltd. are some of the competing market players.

North America Opioids Drug Market Forecast 2019-2027

Table of Contents

1.RESEARCHSCOPE
1.1.STUDYGOALS
1.2.SCOPEOFTHEMARKETSTUDY
1.3.WHOWILLFINDTHISREPORTUSEFUL?
1.4.STUDYANDFORECASTINGYEARS
2.RESEARCHMETHODOLOGY
2.1.SOURCESOFDATA
2.1.1.SECONDARYDATA
2.1.2.PRIMARYDATA
2.2.TOPDOWNAPPROACH
2.3.BOTTOM-UPAPPROACH
2.4.DATATRIANGULATION
3.EXECUTIVESUMMARY
3.1.MARKETSUMMARY
3.2.KEYFINDINGS
3.2.1.OXYCODONEHOLDSTHELARGESTMARKETSHAREINTERMSOFPRODUCT
3.2.2.ANESTHESIAISTHEMAJORLYUSEDAPPLICATION
4.MARKETDYNAMICS
4.1.MARKETSCOPE&DEFINITION
4.2.MARKETDRIVERS
4.2.1.INCREASINGROADACCIDENTSANDSURGICALPROCEDURES
4.2.2.ESCALATINGPALLIATIVECAREFORPATIENTSSUFFERINGINTENSELY
4.2.3.USAGEOFABUSEDETERRENTFORMULATIONSTORESTRICTTHEOPIOIDABUSE
4.2.4.GROWINGOCCURRENCEOFCHRONICPAIN
4.3.MARKETRESTRAINTS
4.3.1.MISUSEOFOPIOIDS
4.3.2.STRINGENTREGULATORYFRAMEWORK
4.4.MARKETOPPORTUNITIES
4.4.1.INCREASINGUSEOFEXTENDED-RELEASEOPIOIDFORMULATIONS
4.4.2.WIDERANGEOFAPPLICATIONSOFOPIOIDSINTHETHERAPEUTICMANAGEMENT
4.5.MARKETCHALLENGES
4.5.1.INCREASINGNUMBEROFLAWSUITSCASESAGAINSTOPIOIDSMANUFACTURERS
4.5.2.RISINGOCCURRENCEOFDEATHSRELATEDTOOPIOIDOVERDOSE
5.MARKETBYPRODUCTS
5.1.BUPRENORPHINE
5.2.FENTANYL
5.3.HYDROCODONE
5.4.MORPHINE
5.5.OXYCODONE
5.6.TRAMADOL
5.7.OTHERPRODUCTS
6.MARKETBYAPPLICATION
6.1.PAINRELIEF
6.1.1.CANCERPAIN
6.1.2.POSTOPERATIVEPAINMANAGEMENT
6.1.3.LOWBACKPAIN
6.1.4.ORTHOPEDIC
6.1.5.NEUROPATHIC
6.1.6.FIBROMYALGIA
6.2.ANESTHESIA
6.3.COUGHSUPPRESSION
6.4.DIARRHEASUPPRESSION
6.5.DEADDICTION
7.KEYANALYTICS
7.1.PORTER'SFIVEFORCEMODEL
7.1.1.THREATOFNEWENTRANTS
7.1.2.THREATOFSUBSTITUTE
7.1.3.BARGAININGPOWEROFSUPPLIERS
7.1.4.BARGAININGPOWEROFBUYERS
7.1.5.THREATOFCOMPETITIVERIVALRY
7.2.REGULATORYFRAMEWORK
7.3.PIPELINEANALYSIS
7.4.INDUSTRYEVENTSINOPIOIDDRUGSMARKET
7.5.TECHNOLOGIESADVANCEMENT
7.6.OPPORTUNITYMATRIX
8.GEOGRAPHICALANALYSIS
8.1.NORTHAMERICA
8.1.1.THEUNITEDSTATES
8.1.2.CANADA
9.COMPETITIVELANDSCAPE
9.1.MARKETPOSITIONANALYSIS
9.2.COMPANYPROFILES
9.2.1.ACURAPHARMACEUTICALS,INC.
9.2.2.ALLERGANPLC
9.2.3.BIODELIVERYSCIENCESINTERNATIONAL,INC.
9.2.4.CIPHERPHARMACEUTICALSINC.
9.2.5.COLLEGIUMPHARMACEUTICAL,INC.
9.2.6.DAIICHISANKYO,INC.
9.2.7.EGALETCORP.
9.2.8.HIKMAPHARMACEUTICALSPLC
9.2.9.INDIVIORINC.
9.2.10.INSYSTHERAPEUTICS,INC.
9.2.11.JANSSENPHARMACEUTICALS,INC.
9.2.12.JOHNSON&JOHNSON
9.2.13.LANNETTCO.INC.
9.2.14.LUPINLTD.
9.2.15.MYLANNV
9.2.16.PFIZERINC.
9.2.17.PURDUEPHARMALP
9.2.18.SANOFI-AVENTISS.A.
9.2.19.SUNPHARMACEUTICALINDUSTRIESLIMITED(SUNPHARMA)
9.2.20.TEVAPHARMACEUTICALINDUSTRIESLTD.


List Of Tables

TABLE1NORTHAMERICAOPIOIDSDRUGMARKET2019-2027($MILLION)
TABLE2ANESTHETICEFFECTSOFDRUGSATDIFFERENTOPIOIDRECEPTORS
TABLE3FDAAPPROVEDOPIOIDSWITHADFLABELLING
TABLE4NUMBEROFLAWSUITSCASESSETTLEDBYOPIOIDSMANUFACTURINGCOMPANIESANDPHARMACIES2015-2027
TABLE5NORTHAMERICAOPIOIDSDRUGSMARKETBYPRODUCTS2019-2027($MILLION)
TABLE6NORTHAMERICABUPRENORPHINEMARKET2019-2027($MILLION)
TABLE7NORTHAMERICAFENTANYLMARKET2019-2027($MILLION)
TABLE8NORTHAMERICAHYDROCODONEMARKET2019-2027($MILLION)
TABLE9NORTHAMERICAMORPHINEMARKET2019-2027($MILLION)
TABLE10NORTHAMERICAOXYCODONEMARKET2019-2027($MILLION)
TABLE11NORTHAMERICATRAMADOLMARKET2019-2027($MILLION)
TABLE12NORTHAMERICAOTHERPRODUCTSMARKET2019-2027($MILLION)
TABLE13NORTHAMERICAOPIOIDSDRUGSMARKETBYAPPLICATION2019-2027($MILLION)
TABLE14NORTHAMERICAOPIOIDSDRUGSMARKETBYAPPLICATION2019-2027($MILLION)
TABLE15NORTHAMERICAPAINRELIEFMARKET2019-2027($MILLION)
TABLE16NORTHAMERICAPAINRELIEFMARKETBYTYPES2019-2027($MILLION)
TABLE17NORTHAMERICACANCERPAINMARKET2019-2027($MILLION)
TABLE18NORTHAMERICAPOSTOPERATIVEPAINMANAGEMENTMARKET2019-2027($MILLION)
TABLE19NORTHAMERICALOWBACKPAINMARKET2019-2027($MILLION)
TABLE20NORTHAMERICAORTHOPEDICMARKET2019-2027($MILLION)
TABLE21NORTHAMERICANEUROPATHICMARKET2019-2027($MILLION)
TABLE22NORTHAMERICAFIBROMYALGIAMARKET2019-2027($MILLION)
TABLE23NORTHAMERICAANESTHESIAMARKET2019-2027($MILLION)
TABLE24NORTHAMERICACOUGHSUPPRESSIONMARKET2019-2027($MILLION)
TABLE25NORTHAMERICADIARRHEASUPPRESSIONMARKET2019-2027($MILLION)
TABLE26NORTHAMERICADEADDICTIONMARKET2019-2027($MILLION)
TABLE27LISTOFER/LAOPIOIDBRANDEDDRUGS2017
TABLE28LISTSOFER/LAOPIOIDGENERICDRUGS2017
TABLE29CDCGUIDELINESONPRESCRIBINGOPIOIDS
TABLE30PIPELINEANALYSESOFOPIOIDDRUGS
TABLE31NORTHAMERICAOPIOIDSDRUGSMARKETBYCOUNTRY2019-2027($MILLION)

List Of Figures

FIGURE1NORTHAMERICAOPIOIDSDRUGMARKET2019-2027($MILLION)
FIGURE2NUMBEROFDEATHSINTHEUNITEDSTATESDUETODRUGOVERDOSE2010-2016
FIGURE3NORTHAMERICAOPIOIDSDRUGSMARKETSHAREBYPRODUCTS2018&2027(%)
FIGURE4NORTHAMERICAOPIOIDSDRUGSMARKETSHAREBYAPPLICATION2018&2027(%)
FIGURE5PORTER'SFIVEFORCEMODEL
FIGURE6NORTHAMERICAOPIOIDSDRUGSMARKETREGIONALOUTLOOK2018&2027(%)
FIGURE7THEUNITEDSTATESOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE8NUMBEROFOPIOIDPRESCRIPTIONSDISPENSEDINTHEUNITEDSTATES2015-2017(MILLIONS)
FIGURE9NUMBEROFDRUGOVERDOSEDEATHSINTHEUNITEDSTATES2010-2016
FIGURE10CANADAOPIOIDSDRUGSMARKET2019-2027($MILLION)
FIGURE11OPIOIDSMARKETPOSITIONANALYSIS2017
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs